SCHEMBL12623955

SCHEMBL12623955

COCn1cnc2scc(Cn3c4cc(F)c5c(c4c4c6cccnc6oc(=O)c43)OCC5)c2c1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12624036 0.80 — —
SCHEMBL12623747 0.75 NOS2 (0.31) —
SCHEMBL12624029 0.75 PARP1 (0.30) —
SCHEMBL12623935 0.75 — —
SCHEMBL12624146 0.75 — —
SCHEMBL12623806 0.74 TSHR (0.38) —
SCHEMBL12623890 0.74 — —
SCHEMBL12623848 0.74 CYP2C8 (0.37) —
SCHEMBL12624081 0.74 PARP1 (0.31) —
SCHEMBL12624035 0.73 PARP1 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110104109-A1 TETRACYCLIC INDOLE DERIVATIVES AND THEIR USE FOR TREATING OR PREVENTING VIRAL INFECTIONS MERCK SHARP & DOHME CORP. 2011-05-05 — — US disclosed
US-20110104109-A1 TETRACYCLIC INDOLE DERIVATIVES AND THEIR USE FOR TREATING OR PREVENTING VIRAL INFECTIONS MERCK SHARP & DOHME CORP. 2011-05-05 — — US disclosed
Send feedback